Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Comoglio

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Journal of Cellular Biochemistry|March 1, 1990
Regulation by EGF is maintained in an overexpressed chimeric EGFR/neu receptor tyrosine kinaseH Lehväslaiho, L Sistonen, F diRenzo, et al.
International Journal of Cancer|January 15, 1989
Inhibition of experimental metastasis of murine fibrosarcoma cells by oligopeptide analogues to the fibronectin cell-binding siteS Bretti, P Neri, L Lozzi, et al.
Oncogene|April 1, 1994
Creation of an hepatocyte growth factor/scatter factor autocrine loop in carcinoma cells induces invasive properties associated with increased tumorigenicityS Bellusci, G Moens, G Gaudino, et al.
Clinical & Experimental Metastasis|May 6, 1998
C-met activation is necessary but not sufficient for liver colonization by B16 murine melanoma cellsS Lin, D Rusciano, P Lorenzoni, et al.
Tumori|February 29, 1988
High chemotactic motility and growth in hard agar of a variant of RSV-transformed fibroblasts are lost in late passagesG Allavena, A Melchiori, S Carlone, et al.
The Journal of Biological Chemistry|June 14, 1996
Specific uncoupling of GRB2 from the Met receptor. Differential effects on transformation and motilityC Ponzetto, Z Zhen, E Audero, et al.
The Journal of Clinical Endocrinology and Metabolism|July 1, 1997
Negative/low expression of the Met/hepatocyte growth factor receptor identifies papillary thyroid carcinomas with high risk of distant metastasesA Belfiore, P Gangemi, A Costantino, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 1998
Overexpression of stromelysin-3, BM-40/SPARC, and MET genes in human esophageal carcinoma: implications for prognosisH Porte, J P Triboulet, L Kotelevets, et al.
British Journal of Cancer|January 1, 1997
Progression of familial adenomatous polyposis (FAP) colonic cells after transfer of the src or polyoma middle T oncogenes: cooperation between src and HGF/Met in invasionS Empereur, S Djelloul, Y Di Gioia, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 10, 2008
Role of cMET expression in non-small-cell lung cancer patients treated with EGFR tyrosine kinase inhibitorsP A Zucali, M G Ruiz, E Giovannetti, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Journal of Cellular Biochemistry|March 1, 1990
Regulation by EGF is maintained in an overexpressed chimeric EGFR/neu receptor tyrosine kinaseH Lehväslaiho, L Sistonen, F diRenzo, et al.
International Journal of Cancer|January 15, 1989
Inhibition of experimental metastasis of murine fibrosarcoma cells by oligopeptide analogues to the fibronectin cell-binding siteS Bretti, P Neri, L Lozzi, et al.
Oncogene|April 1, 1994
Creation of an hepatocyte growth factor/scatter factor autocrine loop in carcinoma cells induces invasive properties associated with increased tumorigenicityS Bellusci, G Moens, G Gaudino, et al.
Clinical & Experimental Metastasis|May 6, 1998
C-met activation is necessary but not sufficient for liver colonization by B16 murine melanoma cellsS Lin, D Rusciano, P Lorenzoni, et al.
Tumori|February 29, 1988
High chemotactic motility and growth in hard agar of a variant of RSV-transformed fibroblasts are lost in late passagesG Allavena, A Melchiori, S Carlone, et al.
The Journal of Biological Chemistry|June 14, 1996
Specific uncoupling of GRB2 from the Met receptor. Differential effects on transformation and motilityC Ponzetto, Z Zhen, E Audero, et al.
The Journal of Clinical Endocrinology and Metabolism|July 1, 1997
Negative/low expression of the Met/hepatocyte growth factor receptor identifies papillary thyroid carcinomas with high risk of distant metastasesA Belfiore, P Gangemi, A Costantino, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 1998
Overexpression of stromelysin-3, BM-40/SPARC, and MET genes in human esophageal carcinoma: implications for prognosisH Porte, J P Triboulet, L Kotelevets, et al.
British Journal of Cancer|January 1, 1997
Progression of familial adenomatous polyposis (FAP) colonic cells after transfer of the src or polyoma middle T oncogenes: cooperation between src and HGF/Met in invasionS Empereur, S Djelloul, Y Di Gioia, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 10, 2008
Role of cMET expression in non-small-cell lung cancer patients treated with EGFR tyrosine kinase inhibitorsP A Zucali, M G Ruiz, E Giovannetti, et al.
Pageof 3